61 related articles for article (PubMed ID: 2613390)
1. The single dose and steady-state pharmacokinetics of a vadocaine tablet in healthy human volunteers.
Silvasti M; Karttunen P; Tukiainen H; Mykkänen M; Hänninen U; Välttilä S
Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):558-63. PubMed ID: 2613390
[TBL] [Abstract][Full Text] [Related]
2. Steady state pharmacokinetics of the new antitussive compound vadocaine hydrochloride.
Silvasti M; Karttunen P; Tukiainen H; Mykkänen M; Ottoila P
Arzneimittelforschung; 1990 Apr; 40(4):453-6. PubMed ID: 2357246
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of graded single doses of the novel antitussive compound vadocaine hydrochloride in healthy male volunteers.
Karttunen P; Männistö PT; Tukiainen H; Uusitupa M; Nissinen E
Arzneimittelforschung; 1988 Apr; 38(4A):635-8. PubMed ID: 3395402
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the antitussive effect of vadocaine hydrochloride using citric acid-induced cough in healthy volunteers.
Karttunen P
Arzneimittelforschung; 1988 Apr; 38(4A):639-41. PubMed ID: 3395403
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the safety margin of vadocaine hydrochloride in man.
Karttunen P; Uusitupa M; Helin M; Tukiainen H; Silvasti M
Arzneimittelforschung; 1988 Apr; 38(4A):642-6. PubMed ID: 3395404
[TBL] [Abstract][Full Text] [Related]
6. First human studies on the safety and antitussive activity of vadocaine hydrochloride.
Karttunen P; Tukiainen H; Uusitupa M; Männistö PT
Arzneimittelforschung; 1988 Apr; 38(4A):631-4. PubMed ID: 3395401
[TBL] [Abstract][Full Text] [Related]
7. Preliminary pharmacokinetics of the new antitussive compound vadocaine hydrochloride in animals.
Mäntylä R; Männistö PT; Vuorela A; Nissinen E
Arzneimittelforschung; 1988 Apr; 38(4A):624-7. PubMed ID: 3395399
[TBL] [Abstract][Full Text] [Related]
8. Tissue distribution of the novel antitussive compound vadocaine hydrochloride in white female mice studied by whole-body autoradiography.
Vuorela A; Mäntylä R; Männistö PT
Arzneimittelforschung; 1988 Apr; 38(4A):628-30. PubMed ID: 3395400
[TBL] [Abstract][Full Text] [Related]
9. Antitussive action of the new anilide derivative vadocaine hydrochloride compared with codeine phosphate in four animal models.
Männistö PT; Karttunen P; Lahovaara S; Nissinen E; Davies JE; Algate DR; Baines MW
Arzneimittelforschung; 1988 Apr; 38(4A):598-604. PubMed ID: 3395394
[TBL] [Abstract][Full Text] [Related]
10. Studies on the nonspecific central nervous system effects of the novel antitussive compound vadocaine hydrochloride.
Karttunen P; Männistö PT; Lahovaara S; Havas A
Arzneimittelforschung; 1988 Apr; 38(4A):605-8. PubMed ID: 3395395
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and ventilator effects of vadocaine hydrochloride in urethane-anaesthetized rats and guinea-pigs.
Paakkari I; Svartström-Fraser M
Arzneimittelforschung; 1988 Apr; 38(4A):617-9. PubMed ID: 3395397
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies on the dependence liability of morphine hydrochloride, codeine phosphate and two novel antitussive compounds vadocaine hydrochloride and N-(2',4'-dimethyl-6'-methoxyphenyl)-4-(diethylamine) butanamide hydrochloride in mice.
Etemadzadeh E; Ahtee L; Männistö PT
Arzneimittelforschung; 1988 Apr; 38(4A):620-3. PubMed ID: 3395398
[TBL] [Abstract][Full Text] [Related]
13. Effects of lidocaine, codeine and vadocaine hydrochloride on platelet aggregation in human platelet-rich plasma.
Kangasaho M
Arzneimittelforschung; 1988 Apr; 38(4A):613-6. PubMed ID: 2840087
[TBL] [Abstract][Full Text] [Related]
14. Single-dose and steady-state pharmacokinetics of fentanyl buccal tablet in healthy volunteers.
Darwish M; Kirby M; Robertson P; Hellriegel E; Jiang JG
J Clin Pharmacol; 2007 Jan; 47(1):56-63. PubMed ID: 17192502
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
Hatorp V; Oliver S; Su CA
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):636-41. PubMed ID: 9877000
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination and pharmacokinetic study of roxithromycin and ambroxol hydrochloride in human plasma by LC-MS/MS.
Hang TJ; Zhang M; Song M; Shen JP; Zhang YD
Clin Chim Acta; 2007 Jul; 382(1-2):20-4. PubMed ID: 17462615
[TBL] [Abstract][Full Text] [Related]
18. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
19. Biovailability and pharmacokinetics of femoxetine.
Mengel H; Lund J; Lange J
Arzneimittelforschung; 1983; 33(3):462-6. PubMed ID: 6683524
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of two opioid antitussives, vadocaine hydrochloride, clobutinol and lidocaine on lung mechanics in guinea-pigs.
Salonen RO
Arzneimittelforschung; 1988 Apr; 38(4A):609-12. PubMed ID: 3395396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
